Emgality 120 mg

EMGALITY 120 MG is a subcutaneous solution containing galcanezumab, used for migraine prevention. This prescription medication is designed to reduce the frequency of migraine headaches in adults.

EMGALITY 120 MG is primarily used for migraine prevention. It is a calcitonin gene-related peptide (CGRP) antagonist, which may help in reducing the number of migraine days experienced by adults. People often ask, 'What is EMGALITY used for?' and the answer is that it is specifically indicated for the preventive treatment of migraines.

Common effects of EMGALITY 120 MG may include injection site reactions, such as redness, pain, or swelling. Some users might experience constipation, upper respiratory infection, or fatigue. These effects vary among individuals and are not exhaustive.

EMGALITY 120 MG should be used with caution in individuals with a history of hypersensitivity to galcanezumab or any of its components. It is important to follow the advice of a healthcare provider regarding its use, especially for those with other medical conditions.

EMGALITY 120 MG may interact with other medications, including those that affect the immune system or blood pressure. It is advisable to inform a healthcare provider about all current medications before starting EMGALITY. Alcohol and certain supplements might also influence its effects.